Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011881 (
diabetic nephropathy
)
10,836
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using streptozotocin-induced diabetic Wistar and GK rats as models of type 1 and type 2 diabetes, respectively, we investigated the changes in serum and urinary
hyaluronidase
activity with the pathological progress. The serum
hyaluronidase
levels of streptozotocin-induced rats started to increase on the third day after injection and thereafter maintained approximately threefold higher levels compared with control rats; those of GK rats were already higher ( approximately twofold) from the beginning of the experiment. The increases of serum
hyaluronidase
activity in both diabetic rats were similar to those of blood glucose level, indicating that diabetes mellitus was accompanied by enhanced activity of circulating
hyaluronidase
from the early phase of its development. In zymography, every serum from diabetic and control rats gave two
hyaluronidase
isomers, a major 73-kDa band (Hyal-1 type) and a minor 132-kDa band, suggesting that the increases in serum
hyaluronidase
activity were not due to the appearance of novel isomers. The
hyaluronidase
activity in 24-h urine of streptozotocin-induced rats was 3-, 7-, and 11-fold higher at the 8th, 15th, and 18th week than that of control rats, respectively, and the urinary
hyaluronidase
activity of GK rats was not significantly different from controls. There was a good correlation between the urinary
hyaluronidase
activity and the albumin excretion. Thus the increase in urinary
hyaluronidase
activity may reflect enhanced glomerular permeability in streptozotocin-induced diabetic rats and may be a useful marker for
diabetic nephropathy
. Relative resistance to SDS-denaturation in zymography of rat serum and urinary hyaluronidases compared with human serum
hyaluronidase
are also shown.
...
PMID:Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK rats. 1455 Dec 18
We investigated changes in renal
hyaluronidase
activity in streptozotocin (STZ)-induced diabetic rats during the progression of diabetes. Prior to the study, we characterized rat renal
hyaluronidase
activity to find that its optimum pH is 3.5 and that it consists of two isomers of 73 and 63 kDa, as detected by zymography. Hyaluronidase activity was traced in one whole kidney and in the cortex and medulla of the other kidney up to the 18th week after STZ injection. Whole kidney
hyaluronidase
activity started to increase on day 3 and reached a maximum level 2.4 times that of the controls in the 3rd week. Cortical
hyaluronidase
showed a similar tendency to that of whole kidney
hyaluronidase
, while medullary
hyaluronidase
activity continued to increase until the 8th week, suggesting their different involvements in the progression of
diabetic nephropathy
. In zymography, the intensities of the two isomer bands increased with the progression of diabetes, but the intensity ratio did not change significantly and no new isomer band appeared. Renal HAase activity increased only in STZ-induced diabetic rats, but not in spontaneously diabetic Goto-Kakizaki rats still without remarkable renal disorder. Based on these findings, increased renal HAase activity may serve as a useful marker for
diabetic nephropathy
.
...
PMID:Increased hyaluronidase activity in the kidney of streptozotocin-induced diabetic rats. 1476 77